|
E-gladesDrug - E-glades The trade name of the product as shown on the labeling.
Dosage -
GEL; TOPICAL
Active Ingredient(s) -
Erythromycin
Strength -
2%
Applicant -
GLADES PHARMS
New Drug Application (NDA) Number -
065009
Product Number -
001
Therapeutic Equivalence (TE) Code -
AT
Approval Date -
Mar 18, 2002
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Glades Pharmaceuticals Inc
E-glades
Invanz Eq 1gm Base/vial Injectable; Intramuscular, Iv (infusion)
Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 250mg Capsule, Delayed Rel Pellets; Oral Eryc 125 125mg Capsule, Delayed Rel Pellets; Oral Eryc Sprinkles 125mg Capsule, Delayed Rel Pellets; Oral Erythromycin 250mg Capsule, Delayed Rel Pellets; Oral Erythromycin 250mg Capsule, Delayed Rel Pellets; Oral E-glades 2% Gel; Topical NewDrugInformation |